Plasma and LDL levels of major lipophilic antioxidants are similar in patients with advanced atherosclerosis and age-matched controls

Free Radical Research

Volumn 26, Issue 2, 1997, Pages 175-182

  Cleary, Janelle ^a   Mohr, Detlef ^a   Adams, Mark R ^b   Celermajer, David S ^a,b   Stocker, Roland ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Coenzyme Q; Lipid hydroperoxides; Oxidative stress; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CHOLESTEROL ESTER; LOW DENSITY LIPOPROTEIN; UBIQUINONE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; OXIDATION REDUCTION STATE; OXIDATIVE STRESS;

EID: 0030841974     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.3109/10715769709097796     Document Type: Article

References (32)

1. D. Steinberg, S. Parthasarathy, T. E. Carew, J. C. Khoo and J. L. Witztum (1989). Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity, New England Journal of Medicine, 320, 915-924.
2. G. W. Burton, A. Joyce and K. U. Ingold (1983). Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membranes? Archives of Biochemistry and Biophysics, 221, 281-290.
3. H. Esterbauer, J. Gebicki, H. Puhl and G. Jürgens (1992). The role of lipid peroxidation and antioxidants in oxidative modification of LDL, Free Radical Biology and Medicine, 13, 341-390.
4. V. W. Bowry and R. Stocker (1993). Tocopherol-mediated peroxidation. The pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein, Journal of American Chemical Society, 115, 6029-6040.
5. A. R. Waldeck and R. Stocker (1996). Radical-initiated lipid peroxidation in low density lipoproteins: Insights obtained from kinetic modeling, Chemical Research in Toxicology, 9, 954-964.
6. V. W. Bowry, D. Mohr, J. Cleary and R. Stocker (1995). Prevention of tocopherol-mediated peroxidation of ubiquinol-10-free human low density lipoprotein, Journal of Biological Chemistry, 270, 5756-5763.
7. J. Neuzil, S. R. Thomas and R. Stocker (1996). Requirement for, promotion, or inhibition by α-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation, Free Radical Biology and Medicine, in press.
8. C. E. Cross, T. Forte, R. Stocker, S. Louie, Y. Yamamoto, B. N. Ames and B. Frei (1990). Oxidative stress and abnormal cholesterol metabolism in patients with adult respiratory distress syndrome, Journal of Laboratory and Clinical Medicine, 115, 396-404.
9. R. Stocker, V. W. Bowry and B. Frei (1991). Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol, Proceedings of the National Academy of Sciences, USA, 88, 1646-1650.
10. 10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low density lipoprotein to the initiation of lipid peroxidation, Biochimica et Biophysica Acta, 1126, 247-254.
11. M. Lemke, B. Frei, B. N. Ames and A. I. Faden (1990). Decrease in tissue levels of ubiquinol-9 and -10, ascorbate and α-tocopherol following spinal cord impact trauma in rats, Neuroscience Letters, 108, 201-206.
12. A. Kontush, C. Hübner, B. Finckh, A. Kohlschütter and U. Beisiegel (1994). Low density lipoprotein oxidizability by copper correlates to its initial ubiquinol-10 and polyunsaturated fatty acid content, FEBS Letters, 341, 69-73.
13. S. R. Thomas, J. Neuzil and R. Stocker (1996). Co-supplementation with coenzyme Q prevents the pro-oxidant effect of α-tocopherol and increases the resistance of low-density lipoprotein towards transition metal-dependent oxidation initiation, Arteriosclerosis, Thrombosis, and Vascular Biology, 16, 687-696.
14. J. Lagendijk, J. B. Ubbink and W. J. H. Vermaak (1996). Measurement of the ratio between the reduced and oxidized forms of coenzyme Q1n in human plasma as a possible marker of oxidative stress, Journal of Lipid Research, 37, 67-75.
15. K. Mukai, S. Itoh and H. Morimoto (1992). Stopped-flow kinetic study of vitamin E regeneration reaction with biological hydroquinones (reduced forms of ubiquinone, vitamin K, and tocopherolquinone) in solution, Journal of Biological Chemistry, 267, 22277-22281.
16. B. Halliwell and J. M. C. Gutteridge (1990). The antioxidants of human extracellular fluids, Archives of Biochemistry and Biophysics, 280, 1-8.
17. R. Stocker and B. Frei (1991). Endogenous antioxidant defenses in human blood plasma, In Oxidative stress: Oxidants and antioxidants (ed. H. Sies) Academic Press, London and New York, pp. 213-243.
18. K. L. Carpenter, K. H. Cheeseman, C. van der Veen, S. E. Taylor, M. K. Walker and M. J. Mitchinson (1995). Depletion of alpha-tocopherol in human atherosclerotic lesions, Free Radical Research, 23, 549-558.
19. C. Suarna, R. T. Dean, J. May and R. Stocker (1995). Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate, Arteriosclerosis, Thrombosis, and Vascular Biology, 15, 1616-1624.
20. W. Sattler, D. Mohr and R. Stocker (1994). Rapid isolation of lipoproteins and assessment of their peroxidation by HPLC postcolumn chemiluminescence, Methods in Enzymology, 233, 469-489.
21. J. K. Lang, K. Gohil and L. Packer (1986). Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions, Analytical Biochemistry, 157, 106-116.
22. Y. Hochberg (1988). A sharper Bonferroni procedure for multiple tests of significance, Biometrika, 75, 800-802.
23. Y. Hanaki, S. Sugiyama, T. Ozawa and M. Ohno (1991). Ratio of low-density lipoprotein cholesterol to ubiquinone as a coronary risk factor, New England Journal of Medicine, 325, 814-815.
24. W. Jessup, D. Mohr, S. P. Gieseg, R. T. Dean and R. Stocker (1992). The participation of nitric oxide in cell free- and its restriction of macrophage-mediated oxidation of low-density lipoprotein, Biochimica et Biophysica Acta, 1180, 73-82.
25. L. J. Hazell and R. Stocker (1993). Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages, Biochemical Journal, 290, 165-172.
26. M. L. Hu, S. Louie, C. E. Cross, P. Motchnik and B. Halliwell (1993). Antioxidant protection against hypochlorous acid in human plasma, Journal of Laboratory and Clinical Medicine, 121, 257-262.
27. C. A. O'Neill, B. Halliwell, A. van der Vliet, P. A. Davis, L. Packer, H. Tritschler, W. J. Strohman, T. Rieland, C. E. Cross and A. Z. Reznick (1994). Aldehyde-induced protein modifications in human plasma: protection by glutathione and dihydrolipoic acid, Journal of Laboratory and Clinical Medicine, 124, 359-370.
28. M. Öhrvall, G. Sundlöf and B. Vessby (1996). Gamma, but not alpha, tocopherol levels in serum are reduced in coronary heart disease patients, Journal of Internal Medicine, 239, 111-117.
29. D. A. Street, G. W. Comstock, R. M. Salkeld, W. Schuep and M. J. Klag (1994). Serum antioxidants and myocardial infarction. Are low levels of carotenoids and alpha-tocopherol risk factors for myocardial infarction? Circulation, 90, 1154-1161.
30. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group (1994). The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers, New England Journal of Medicine, 330, 1029-1035.
31. W. J. Blot, J. Y. Li, P. R. Taylor, W. Guo, S. Dawsey, G. Q. Wang, C. S. Yang, S. F. Zheng, M. Gail, G. Y. Li and et al. (1993). Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population, Journal of the National Cancer Institute, 85, 1483-1492.
32. N. G. Stephens, A. Parsons, P. M. Schofield, F. Kelly, K. Cheeseman, M. J. Mitchinson and M. J. Brown (1996). Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS), Lancet, 347, 781-786.